The cell surface expression of alpha:beta heterodimer was studied using WT31 monoclonal antibody, in peripheral blood lymphocytes (PBL) from a patient who developed a prolonged immunodeficiency after allogeneic bone marrow transplantation. This patient, grafted for chronic myelogenous leukemia, received T cell depleted bone marrow from her HLA, A, B, D matched sibling. The late occurrence of opportunistic infection, led us to analyze the phenotype of patient PBL. 70% of PBL were CD3+ and 29% WT31+, indicating that the majority of CD3+ PBL did not express the alpha:beta heterodimer. Transcription of the genes encoding the alpha, beta, and gamma chains was assessed in cell lines derived from PBL, by Northern blot analysis. We showed that the CD3+ WT31-subset expressed a truncated, beta mRNA (1.0 kb) and also truncated alpha transcript (1.4 kb). To determine the CD3-associated structure on CD3+ WT31-cell line, immunoprecipitation assays were performed using monoclonal anti-CD3 and an hetero antiserum against gamma peptides. These CD3+ WT31-cells expressed a disulfide linked dimer, composed of products of gamma gene (37 kD, 40 kD) and of undefined delta chain (45 kD). Functional analyses were performed in PBL before and after sorting with WT31 and anti-CD3 antibody. These circulating CD3+ WT31-cells were unable to proliferate when triggered with anti-T3 beads and they seemed to mediate a suppressor activity on […] 
Introduction
Two different T cell receptors (TCR)' have so far been identified, the a:, heterodimer expressed on CD4 and CD8 cells and a recently described dimer composed of products of y gene and 6 chain (1-1 1). Both dimers are independently expressed on the cell surface of distinct subsets of T cells, in association with the CD3 (T3) complex. Recent studies of the ontogeny of TCR/CD3 complex have shown that y:6 dimer is first de- 1 . Abbreviations used in this paper: BMT, bone marrow transplantation; CMV, cytomegalovirus; GVHD, graft versus host disease; TCR, T cell receptor. tected, 2 d before the cell surface expression of a:3 heterodimer (12, 13) but it is not yet clear whether cells expressing y chains require thymus processing. These TCR y:6 cells, which were mainly double negative, CD4-CD8-, represent a minor subset, about 6% of normal adult peripheral blood lymphocytes (PBL) (10, 14) . They have been isolated and characterized from fetal blood (1) from the leukemia cell line termed PEER (4) and from the cell lines established from PBL of two patients with congenital immunodeficiency (3) .
In the setting of allogeneic bone marrow transplantation (BMT), the differentiation of immature donor T lymphocytes is required to achieve functional immune reconstitution. Abnormal differentiation of donor T cells in the recipient is thus to be expected since the immunodeficient state persisted several months after grafting (15) . Consequently, we have sought to analyze the surface expression of two distinct TCRs in PBL from grafted patients. (MAb) termed WT3 1, which reacts with a nonpolymorphic determinant expressed on a:# heterodimer may be used to identify T lymphocytes that do or do not express a:# chains (16) .
Interestingly, a predominant circulating subset of CD3+ WT3 1-cells was detected in one of our patients who received T cell-depleted bone marrow from her HLA matched donor. The characteristics of CD3 associated structure was studied in these CD3+ WT3 1-cells that did not transcribe functional a and ,B mRNA. We showed that a disulfide linked dimer composed of y and 6 chains was expressed on the cell surface ofthis subset. Functional analysis was performed in patient PBL before and after sorting with WT3 1 and anti-CD3 MAb; a relationship between the in vivo expansion of these TCR y:6 bearing cells and the immunodeficient state was shown.
Methods

Patient
In August 1985, a 23-yr-old female was grafted for Philadelphia positive chronic myelogenous leukemia in an accelerated phase. Details of the BMT procedure and supportive care have been published elsewhere (17, 18) . The pretransplant conditioning regimen consisted of Belustine, 100 mg/M2; cyclophosphamide, 120 mg/kg and total body irradiation (a single dose of 10 Gy). The donor was a class-I and -II HLA compatible brother. In vitro depletion of T lymphocytes from donor marrow was achieved with a cocktail of three murine MAbs (anti-CD2, CD5, and anti CD7) plus baby rabbit complement-mediated lysis. The donor T cell-depleted marrow was evaluated for residual T lymphocytes by a limiting dilution assay that determined the frequency of PHA IL-2 responsive T lymphocytes, according to the method already described ( 19) . Total residual clonable T lymphocytes, infused to the recipient, was estimated at 4.106 cells/kg. Hematological reconstitution was observed within 6 wk postgrafting. Cytogenetic analysis showed the complete disappearance of Philadelphia chromosome and the exclusive presence of donor hematopoietic cells, 6 mo after BMT. As prophylaxis of graft versus host disease (GVHD), cyclosporine A was given according to our protocol (17) and was associated with methotrexate (days 1, 3, 6, 1 1). On day 86, the patient developed mild GVHD grade 1 proven by skin biopsy, treated with a course of steroids. Cyclosporine A was stopped 6 mo postgrafting. A limited chronic GVHD occurring I yr after BMT, was treated with 6-mercaptopurin and steroids.
Disseminated and prolonged cytomegalovirus (CMV) infection occurred from week 7 until the week 24, characterized by the repeated isolation of CMV from blood, and by the late development of severe CMV retinitis and uveitis in week 24 postgrafting. This unusual complication was associated with important lesions ofvascularitis responsible for the occurrence of blindness despite several courses of ganciclovir (9-[2-hydroxy-I-(hydroxymethyl) ethoxymethyl] guanine) (20 
Northern blot analysis
Total cellular RNA was prepared by resuspending the cells in 4 M guanidine, thiocyanate, subjecting them to disruption with a polytron homogenizer (Brinkmann Instruments, Inc., Westbury, NY) and pelleting them through 5.7 M Cs Cl2 pad (23) . RNA was electrophoresed in 7% formaldehyde, 1% agarose gels, blotted to nitrocellulose filters, and hybridized to 32p labeled DNA probes as described (24). The Tc a probe was a 350-bp long fragment encompassing most of the constant region, the transmembrane encoding domain and some of the 3' flanking sequence and was isolated from the PGA 5 cDNA clone (kindly provided by E. Palmer, National Jewish Hospital, Denver, CO). The Tc 13 probe was a 391-bp long Xho2 genomic fragment representing part of the C(3 encoding sequence. The Tc y probe was a 505 bp long, Bam H1 -AccI fragment isolated from the cDNA PHT 'y 9 (provided by J. L. Strominger).
Biochemical characterization of the CD3-associated molecules Antibodies. The rabbit anti-serum against the a-subunit of the human T cell receptor, termed H36, was prepared by M. Fabbi as described (25) . W6.32 (IgG2a) is a mouse monoclonal antibody which recognizes a common antigenic determinant of HLA-A, B, C antigens. UCH-TI (IgGI) is an anti-CD3 monoclonal antibody with potent mitogenic properties (26) . Rabbit anti-serum against the y-subunit ofthe human TCR was a generous gift of T. Hercend (Institut Gustave Roussy, Villejuif) and was prepared as described (8) . Rabbit antibodies against mouse immunoglobulin were purified by affinity chromatography on mouse IgG coupled to Affi-gel 10 (Bio-Rad Laboratories, Richmond, CA).
Radiolabeling. Cell surface proteins were labeled by lactoperoxidase-catalyzed-iodination (27 Electrophoresis analyses. Polyacrylamide slab gels were electrophoresed in the SDS buffer of Maizel and Laemmli, as described (29) .
The gels were run, fixed, and dried as previously described. Samples for electrophoresis were dissolved in 2% (vol/vol) SDS, 10% (vol/vol) glyc- 1--. No discrepancy between the percentage of CD3+ and WT3 1+ lymphocytes was observed 3 mo postgrafting. This CD3+ WT31-subset of circulating PBL appeared between 3 and 6 mo and remained stable 1 yr after BMT (Table I) 7) . These immunoprecipitates were analyzed on a 13%1 S1S-PAGE in reducing (lanes 1-4) or in nonreducing conditions (lanes 5-7).
ger RNAs encoding TCR a and fB chains by Northern blotting.
To obtain phenotypically homogenous cell lines, the following procedures were carried out: CD3+ sorted PBL were expanded to obtain cell lines that were 100% CD3+ and 30% WT31+. Subsequent sorting of these cell lines, using WT31 MAb yielded a homogeneous population of CD3+ WT3 1-cells (< 5% contamination of WT31 + cells) and CD3+ WT31+ cells.
The CD3+ WT3 1-ceU line was CD4 negative 30% CD8 dim-positive and the cytogenetic analysis confirmed that these cells originated from the male donor.
As expected, the CD3+ WT31+ cell line (Fig. 1, lane C) , expressed a 1.3-kb /B transcript, and a 1.7-kb a transcript. In contrast the CD3+ WT3 1-cell line (Fig. 1, lane D) 
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;-I complex on their cell surfaces, the I251 labeled lysates were reacted with an anti-CD3 antibody UCHTI, using the digitonin, a detergent known to maintain the association TCR-CD3. A disulfide linked structure of 90 kD was immunoprecipitated with the CD3 complex in the CD3+ WT3 1-cell line (Fig. 2,  lane 5) . Upon reducing conditions, the 90 kD structure dissociated into three subunits of 45, 40, and 37 kD (Fig. 2, lane 1) . Two-dimensional diagonal gel electrophoresis was used to analyze these three subunits. Anti CD3 immunoprecipitates were separated by SDS-PAGE under nonreducing conditions in the first dimension followed by reduction and separation upon reducing conditions in the second dimension. As shown in Fig.  3 , all three 45-, 40-, and 37-kD subunits were observed directly below the diagonal suggesting that the 90-kD reduced structure is composed of disulfide linked dimeric pairs of these subunits. After autoradiography of the frozen gel, spots corresponding to the molecular range of 30 to 50 kD were eluted. This mixture of spots was immunoprecipitated by anti-T y (Fig. 4, lane 2) or anti-T a serum (Fig. 4, lane 3) . Fig. 4 , lane I shows the two-dimensional SDS-PAGE eluted material. As anti-C y serum reacted with the 37-and 40-kD subunits but not with the 45-kD subunit, it suggested that the 37-and the 40-kD subunits expressed on CD3+ WT3 1-cell line are y chains encoded proteins. The 45-kD subunit may correspond to the 5 chain.
Functional analysis. 6 
Discussion
In the patient with sustained immunodeficiency after BMT, the majority of the CD3+ PBL was shown not to express the cell surface a:(# heterodimer. These CD3+ cells did not bear the antigenic determinants recognized by WT31 'MAb that reacts with shared determinants on a and , subunits. In normal controls, we confirmed that this subset remains minor and does not account for more than 10% of PBL. To determine why the majority of circulating CD3+ cells failed to react with WT3 1 MAb, gene expression was examined on the cell lines using probes specific for a, fl, and 'y genes. The CD3+ WT3 1-cell line expressed a truncated , transcript (1.0 kb), which may be considered as nonfunctional (30) . A short 1.4-kb a transcript, but not a mature 1.7-kb mRNA, was also detected. It is worth noting that no functional a chain. transcript is generally detected in T cells bearing y chains. Nevertheless, short 1.4 kb a transcripts were found in the early stage of thymocyte development in the mouse (31) and it has been demonstrated that the CD4-CD8-thymocytes expressing a 1.4-kb a transcript bear y chains on their cell surfice (2) . By analogy with the ,B gene, this shorter transcript is probably nonfunctional and may result from either partial rearrangement or aberrant transcript of a germline gene (31) .
To further investigate the CD3-associated molecules, sequential immunoprecipitations were conducted using anti-CD3 antibodies and hetero antiserum anti-C y raised against synthetic y chain peptide. We have shown that the CD3+ WT3 1-cell line expressed disulfide linked dimeric pairs of y chains, 37 and 40 kD and a non-y product, 45 kD termed 5. As other authors (6) we have demonstrated that both y subunits are expressed on the same cells (32), using T cell clones. Further studies are required to determine whether these three subunits are associated on the cell surface as -y:y homodimers, or -y;6 heterodimers. It is interesting to note that TCR y:6 bearing cells isolated from pathological samples, immunodeficient T cell lines (3) or PEER T cell line (4) expressed a nondisulfide linked heterodimer, whereas the TCR y:b cells of our patient expressed disulfide-linked dimers, as the subset isolated from normal controls. Actually, this difference in the TCR gamma structure reflects the preferential use of two different Cy genes (33, 34) .
Finally, we showed that this patient predominantly ex- However this functional role cannot yet be generalized to functions of minor TCR y:b subset normally residing in peripheral blood since the patient TCR -y:b cells presented some distinct characteristics similar to immature T cells. As murine fetal TCR y:6 thymocytes, they expressed a short a transcript and they are unable to proliferate when triggered with anti-CD3 beads (2, 13) . It may be possible that the thymus which generates the selection process of T cells was impaired after BMT, by several factors, including total irradiation, chemotherapy, viral infections, cyclosporine A. An ineffective elimination mechanism due to this impaired thymus might explain that the pool of TCR y:b thymocytes tends to increase and leave the thymus. Alternatively, the expansion of immature T cells may be explained by a preferential extrathymic pathway of differentiation after grafting since it has been demonstrated that young athymic mice expressed predominantly TCR y:b cells in periphery (37) .
